FLUOXETINE axapharm caps 20 mg 100 pce
7680594100039
CH-59410
N06AB03
01.06.0.
1 / 3
google
Details
- Product number
- 5941001
- CPT
- -
- Packaging group
- 100
- Unit
- Kapsel(n)
- Composition
- fluoxetinum 20 mg ut fluoxetini hydrochloridum, lactosum monohydricum 146.6 mg, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, Kapselhülle: gelatina, E 171, E 172 (flavum), E 104, E 132, pro capsula.
Articles (1)
Fluoxetin Axapharm, Kapseln
Kapseln
100
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
fluoxetinum
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
fluoxetini hydrochloridum
|
- | Substance | WIZUS |
|
lactosum monohydricum
|
146.6 MG | Substance | HBESI |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
gelatina
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
E 104
|
- | Substance | FIMDK |
|
E 132
|
- | Substance | FIMDK |
Authorization holder
axapharm ag
6340 Baar
Authorization information
- Swissmedic authorization number
- 59410
- Drug name
- Fluoxetin Axapharm, Kapseln
- Galenic form
- KAPS
- ATC Code
- N06AB03
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- B
- First authorization
- 03/04/2009
- Authorization expiration date
- 04/06/2026
- IT number
- 01.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FLUOXETINE axapharm caps 20 mg 100 pce
- Description (DE)
- FLUOXETIN axapharm Kaps 20 mg 100 Stk
- Market launch
- 03/04/2009
- Market withdrawal
- 30/06/2026
- Narcotic (BTM)
- No
Available generics
Fluoxetin-Mepha Dispersible, Tabletten zur Herstellung einer Suspension zum Einnehmen
GTIN:
7680572350043
CHF 12.75
Fluoxetin-Mepha Dispersible, Tabletten zur Herstellung einer Suspension zum Einnehmen
GTIN:
7680572350104
CHF 26.80
Fluoxetin-Mepha Dispersible, Tabletten zur Herstellung einer Suspension zum Einnehmen
GTIN:
7680572350166
CHF 54.35